India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
How to use the 5 listed social media platforms? Although TikTok and Viber are among the platforms used by Nepalis, many may not know about Nimbuzz, WeTalk, and PopoLive. With the government's decision to ban unlisted social media platforms, various debates are currently taking place for and against it. Some are calling this government move a good one, while others are strongly opposing it. Meanwhile, there is more interest in platforms such as Facebook, YouTube, and WhatsApp that Nepalis use daily. According to the details provided by the government, five social media platforms have already been listed. TikTok, Viber, Nimbuzz, WeTalk, and PopoLive will continue to operate regularly in Nepal. Although TikTok and Viber are among the platforms used by Nepalis, many may not know about Nimbuzz, WeTalk, and PopoLive. Which we have presented here in a simple way: TikTok TikTok is a platform for posting short videos. Currently, you can only post photos on it. It can be used through the Ti...